newsfilter
← Latest News
PR Newswire·

Medivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September 16

Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical...